Biora Therapeutics, Inc.

CIK 1580063 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biora Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 4, 2025SCHEDULE 13G/A0000902664-25-003345
Aug 4, 2025SCHEDULE 13G0001539497-25-002007
Jul 10, 2025SCHEDULE 13G/A0001301396-25-000008
Jun 4, 202525-NSE0001354457-25-000496
Mar 26, 2025SCHEDULE 13D/A0000950170-25-045642
Dec 30, 20248-K0001213900-24-113256
Dec 16, 202440000950170-24-136829
Dec 10, 20248-K0000950170-24-134755
Nov 15, 20248-K0000950170-24-127568
Nov 14, 20248-K0000950170-24-127030
Nov 14, 2024SC 13G0000902664-24-006541
Nov 14, 202410-Q0000950170-24-127060
Oct 29, 2024424B50001193125-24-246212
Oct 29, 2024424B30001193125-24-246197
Oct 29, 2024424B30001193125-24-246189
Oct 29, 2024424B30001193125-24-246201
Oct 29, 2024424B30001193125-24-246181
Oct 29, 2024424B30001193125-24-246203
Oct 29, 20248-K0001193125-24-246602
Oct 23, 2024DEF 14A0001193125-24-241883
Oct 11, 2024PRE 14A0001193125-24-236748
Oct 11, 20248-K0000950170-24-114214
Oct 9, 2024SC 13D/A0001193125-24-235295
Oct 7, 20248-K0000950170-24-113271
Sep 16, 2024DEF 14A0001193125-24-219636